Oruka Therapeutics, Inc. · NASDAQ:ORKA
Viking Global Investors LP reported a 5.30% stake in Oruka Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Viking Global Investors LP reported a 5.30% stake in Oruka Therapeutics, Inc., 2,666,690 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 5.30%
- Shares
- 2,666,690
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 5.30% | 2,666,690 |
| Viking Global Opportunities Parent GP LLC | 5.30% | 2,666,690 |
| Viking Global Opportunities GP LLC | 3.20% | 1,600,014 |
| Viking Global Opportunities Portfolio GP LLC | 3.20% | 1,600,014 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 3.20% | 1,600,014 |
| Viking Global Opportunities Drawdown GP LLC | 2.10% | 1,066,676 |
| Viking Global Opportunities Drawdown Portfolio GP LLC | 2.10% | 1,066,676 |
| Viking Global Opportunities Drawdown (Aggregator) LP | 2.10% | 1,066,676 |
| HALVORSEN OLE ANDREAS | 5.30% | 2,666,690 |
| Shabet Rose Sharon | 5.30% | 2,666,690 |
Source
Related
- Oruka Therapeutics, Inc.
- Viking Global Investors LP
- Oruka Therapeutics, Inc. shareholders
- Schedule 13G/A · Viking Global Investors LP · Aug 14, 2026
- Schedule 13G · Viking Global Investors LP · Sep 24, 2025
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026